Showing results (1751-1760 of 1,799) with videos related to

Sort By:
Pageof 180
The New England Journal of Medicine|November 18, 2014
Improved overall survival in melanoma with combined dabrafenib and trametinibCaroline Robert, Boguslawa Karaszewska, Jacob Schachter, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanomaCaroline Robert, Wen-Jen Hwu, Omid Hamid, et al.
Neurology|July 23, 1998
Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trialA Handforth, C M DeGiorgio, S C Schachter, et al.
Epilepsy & Behavior : E&B|June 15, 2013
Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1)Ivan Rektor, Steven C Schachter, Shahar Arzy, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trialsDirk Schadendorf, Georgina V Long, Daniil Stroiakovski, et al.
Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Blood|June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaRobert E Gallagher, Barry K Moser, Janis Racevskis, et al.
Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
Pageof 180